Generating synthetic cohorts of real-world patients with metastatic breast cancer to accelerate collaboration

被引：0

作者：

Batlle, Marta ^{[1
]}

Sanglier, Thibaut ^{[2
]}

Labaki, Chris ^{[3
]}

Bakouny, Ziad ^{[3
]}

Braun, David A. ^{[4
]}

Bouquet, Fanny ^{[1
]}

Joyce, Maureen Ann ^{[5
]}

Martin, Miguel Valero ^{[1
]}

Xie, Wanling ^{[3
]}

Tolaney, Sara M. ^{[6
]}

Choueiri, Toni K. ^{[3
]}

机构：

[1] F Hoffmann La Roche, Basel, Switzerland

[2] F Hoffmann La Roche Ltd, Basel, Switzerland

[3] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA

[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA

[5] Genentech Inc, San Francisco, CA USA

[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

874

引用

页码：408 / 409

页数：2

共 50 条

[31] Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
Rugo, Hope S.
Liu, Xianchen
Li, Benjamin
McRoy, Lynn
Chen, Connie
Layman, Rachel M.
Brufsky, Adam
ONCOLOGIST, 2023, 28 (10): : 866 - 874
[32] Treatment strategies in patients with Metastatic Breast Cancer: real-world practice in the United Kingdom (UK) and Italy
Ferrari, L.
Gerratana, L.
Jove, M.
Bonotto, M.
Cinausero, M.
Iacono, D.
Fontanella, C.
Bozza, C.
Fanotto, V.
Basile, D.
Pelizzari, G.
Vitale, M. G.
Minisini, A.
Mansutti, M.
Russo, S.
Andreetta, C.
Fasola, G.
Puglisi, F.
Twelves, C.
ANNALS OF ONCOLOGY, 2016, 27
[33] Real-world treatment patterns among metastatic breast cancer patients by BRCA status and phenotype.
Sebby, Wendy
Liede, Alexander
Mazumder, Debasish
Ghosh, Anirban
Papademetriou, Eros
Potluri, Ravi C.
Bach, Bruce Allen
Tyczynski, Jerzy Edward
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[34] Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectiveness
Brufsky, Adam
Liu, Xianchen
Li, Benjamin
McRoy, Lynn
Chen, Connie
Makari, Doris
Layman, Rachel M.
Rugo, Hope S.
ONCOLOGIST, 2024, 29 (12): : 1032 - 1043
[35] Real-World Efficacy of Fulvestrant Monotherapy as the First Treatment or Maintenance Treatment in Patients with Metastatic Breast Cancer
Lv, Meng
Mao, Yan
Ma, Teng
Wang, Yongmei
Liu, Xiaoyi
Song, Yuhua
Wang, Haibo
BREAST CARE, 2021, 16 (04) : 368 - 375
[36] Real-world outcomes among patients with HER2+metastatic breast cancer with brain metastases
DeBusk, Kendra
Ike, Chiemeka
Lindegger, Nicolas
Schwartz, Naomi
Surinach, Andy
Liu, Yutong
Forero-Torres, Andres
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 657 - 666
[37] Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients.
Olufade, Temitope O.
Skinner, Karen E.
Di Santo, Nicola
Shenolikar, Rahul A.
Walker, Mark Stephen
Schwartzberg, Lee Steven
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38] Novel prognostic staging system for patients with de novo metastatic breast cancer: A real-world experience
Khamees, Ibrahim
Mahadevia, Himil
Gosch, Kensey
Sharma, Parth
Chandra, Simran
Gast, Kelly C.
Pluard, Timothy J.
Hensing, Whitney L.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[39] Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
Skinner, Karen E.
Walker, Mark S.
Haiderali, Amin
Schwartzberg, Lee Steven
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[40] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
Varella, Leticia
Eziokwu, Akaolisa Samuel
Jia, Xuefei
Kruse, Megan
Moore, Halle C. F.
Budd, George Thomas
Abraham, Jame
Montero, Alberto J.
BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434

← 1 2 3 4 5 →